These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2911849)

  • 1. Prediction of individual dosage requirements for lignocaine: a validation study for Bayesian forecasting in Japanese patients.
    Uematsu T; Hirayama H; Nagashima S; Yamazaki T; Tsuchiya N; Sato R; Nakashima M
    Ther Drug Monit; 1989; 11(1):25-31. PubMed ID: 2911849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study for validation of Bayesian prediction approach to adjust individual lidocaine dosage.
    Uematsu T; Hirayama H; Umemura K; Kosuge K; Nakashima M
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):33-7. PubMed ID: 8199750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval.
    Vozeh S; Uematsu T; Hauf GF; Follath F
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):203-12. PubMed ID: 4057058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid prediction of individual dosage requirements for lignocaine.
    Vozeh S; Berger M; Wenk M; Ritz R; Follath F
    Clin Pharmacokinet; 1984; 9(4):354-63. PubMed ID: 6467768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive performance of Bayesian and nonlinear least-squares regression programs for lidocaine.
    Destache CJ; Hilleman DE; Mohiuddin SJ; Lang PT
    Ther Drug Monit; 1992 Aug; 14(4):286-91. PubMed ID: 1519302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias.
    Thomson AH; Kelman AW; de Vane PJ; Hillis WS; Whiting B
    Ther Drug Monit; 1987 Sep; 9(3):283-91. PubMed ID: 3672571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performance.
    Vozeh S; Uematsu T; Ritz R; Schmidlin O; Kaufman G; Scholer A; Follath F
    Am Heart J; 1987 Apr; 113(4):928-33. PubMed ID: 3565242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting serum lithium concentration using Bayesian method: a comparison with other methods.
    Higuchi S; Fukuoka R; Aoyama T; Horioka M
    J Pharmacobiodyn; 1988 Mar; 11(3):158-74. PubMed ID: 3411433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lignocaine therapy after acute myocardial infarction.
    Chopra MP; Portal RW; Aber CP
    Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for Predicting Warfarin Dose Requirements.
    Saffian SM; Wright DF; Roberts RL; Duffull SB
    Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.
    Joel SE; Bryson SM; Small M; Hillis WS; Kelman AW; Whiting B
    Ther Drug Monit; 1983; 5(3):271-7. PubMed ID: 6636255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of a two-compartment Bayesian forecasting method for lidocaine.
    Beach CL; Farringer JA; Peck CC; Crawford MH; Ludden TM; Clementi WA
    Ther Drug Monit; 1988; 10(1):74-9. PubMed ID: 3376185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral lignocaine: its absorption and effectiveness in ventricular arrhythmia control.
    Parkinson PI; Margolin L; Dickson DS
    Br Med J; 1970 Apr; 2(5700):29-30. PubMed ID: 5440571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction.
    Horowitz JD; Anavekar SN; Morris PM; Goble AJ; Doyle AE; Louis WJ
    J Cardiovasc Pharmacol; 1981; 3(3):409-19. PubMed ID: 6168823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intravenous lignocaine on depth of anaesthesia and intraoperative haemodynamics during open radical prostatectomy.
    Weinberg L; Jang J; Rachbuch C; Tan C; Hu R; McNicol L
    BMC Res Notes; 2017 Jul; 10(1):248. PubMed ID: 28683817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient comfort and plasma lignocaine concentrations during fibreoptic bronchoscopy.
    Sutherland AD; Santamaria JD; Nana A
    Anaesth Intensive Care; 1985 Nov; 13(4):370-4. PubMed ID: 4073449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lignocaine concentrations associated with extradural analgesia in patients with and without multiple organ failure.
    Putensen C; Lingnau W; Putensen-Himmer G; Herold M
    Br J Anaesth; 1992 Nov; 69(5):513-6. PubMed ID: 1467084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.